Avricore Health (AVCRF) Convertible Debt (2014)
Avricore Health (AVCRF) posted quarterly Convertible Debt of $15163.7 for Q3 2014, down 49.83% quarter-over-quarter from $30225.9 in Q2 2014.
Avricore Health (AVCRF) Convertible Debt (2014) Analysis & Trends
Avricore Health (AVCRF) has reported Convertible Debt for 1 consecutive years, with $15163.7 the latest figure, recorded in Q3 2014.
- In Q3 2014, Convertible Debt changed N/A year-over-year to $15163.7; the TTM figure through Sep 2014 stood at $15163.7 (changed N/A YoY), while the FY2014 annual figure was $30840.1, changed N/A from the prior year.
- Convertible Debt fell to $15163.7 in Q3 2014 per AVCRF's latest filing, from $30225.9 in the prior quarter.
- Across five years, Convertible Debt topped out at $30225.9 in Q2 2014 and bottomed at $15163.7 in Q3 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 15,163.72 |
| Jun 30, 2014 | 30,225.87 |